Pancreatic Cancer
A PHASE 1B STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF AMG 193 IN COMBINATION WITH OTHER THERAPIES IN SUBJECTS WITH ADVANCED GASTROINTESTINAL, BILIARY TRACT OR PANCREATIC CANCERS WITH HOMOZYGOUS MTAP DELETION (20230223)
- Details
ClinicalTrials.gov ID:
NCT06360354
Diagnosis Type:
NA
USOR Number:
- Address
,
P: